editor@ijphdt.com
9343055451
e-ISSN: 3049-1630
logo

International Journal of Pharmacognosy and Herbal Drug Technology

LoginTrack
Published

Phytoestrogens for Polycystic Ovary Syndrome (PCOS): Natural Approaches to Hormonal Balance

Jai Shankar Pandey
,
Prashant Kumar
,
Aditya Kumar Jaiswal
,
Rohit Rajak
,
Shubham Kumar Maurya
doi_icon
10.64063/3049-1630.vol3.issue4.000243

Published in IJPHDT, Vol-3, Issue-04, April-2026 (Vol. 3, Issue 4, 2026)

Phytoestrogens for Polycystic Ovary Syndrome (PCOS): Natural Approaches to Hormonal Balance - Issue cover

Keywords

PhytoestrogensInsulin SensitivityGenisteinType 2 DiabetesPCOS

Abstract

Phytoestrogens, a diverse group of naturally occurring plant-derived chemicals that resemble estradiol, have garnered considerable interest for their potential effects on insulin sensitivity and glucose metabolism. These chemicals primarily exert their effects via estrogen receptors and numerous signaling pathways, including PI3K/Akt, AMPK, and PPARγ, therefore influencing glucose absorption, lipid metabolism, and inflammatory responses. Experimental and clinical investigations have demonstrated favorable benefits of phytoestrogens, notably isoflavones such as genistein and daidzein, in diminishing insulin resistance, enhancing β-cell functionality, and alleviating characteristics of metabolic syndrome. Nonetheless, interindividual heterogeneity, particularly concerning gut microbiota and equol-producing capability, influences efficacy findings. Although phytoestrogens provide a botanical and practical method for addressing insulin resistance and associated metabolic conditions, such as type 2 diabetes and PCOS, comprehensive safety data and extensive clinical validation are still insufficient. This review rigorously examines the mechanisms of action, preclinical and clinical data, and prospective therapeutic potential of phytoestrogens in enhancing insulin sensitivity.

References

  1. [1]1. Petrine, J. C. P.; Del Bianco-Borges, B. The Influence of Phytoestrogens on Different Physiological and Pathological Processes: An Overview. Phytotherapy Research 2021, 35 (1), 180–197. https://doi.org/10.1002/PTR.6816.
  2. [2]2. Villa, P.; Costantini, B.; Suriano, R.; Perri, C.; Macrì, F.; Ricciardi, L.; Panunzi, S.; Lanzone, A. The Differential Effect of the Phytoestrogen Genistein on Cardiovascular Risk Factors in Postmenopausal Women: Relationship with the Metabolic Status. J Clin Endocrinol Metab 2009, 94 (2), 552–558. https://doi.org/10.1210/JC.2008-0735.
  3. [3]3. Cederroth, C. R.; Vinciguerra, M.; Gjinovci, A.; Kühne, F.; Klein, M.; Cederroth, M.; Caille, D.; Suter, M.; Neumann, D.; James, R. W.; Doerge, D. R.; Wallimann, T.; Meda, P.; Foti, M.; Rohner-Jeanrenaud, F.; Vassalli, J. D.; Nef, S. Dietary Phytoestrogens Activate AMP-Activated Protein Kinase With Improvement in Lipid and Glucose Metabolism. Diabetes 2008, 57 (5), 1176–1185. https://doi.org/10.2337/DB07-0630.
  4. [4]4. HERBS AND SPICES - NEW PERSPECTIVES IN HUMAN HEALTH AND FOOD INDUSTRY. 2024.
  5. [5]5. Lee, C. C.; Bloem, C. J.; Kasa-Vubu, J. Z.; Liang, L. J. Effect of Oral Phytoestrogen on Androgenicity and Insulin Sensitivity in Postmenopausal Women. Diabetes Obes Metab 2012, 14 (4), 315–319. https://doi.org/10.1111/J.1463-1326.2011.01532.X;WGROUP:STRING:PUBLICATION.
  6. [6]6. Jungbauer, A.; Medjakovic, S. Phytoestrogens and the Metabolic Syndrome. J Steroid Biochem Mol Biol 2014, 139, 277–289. https://doi.org/10.1016/J.JSBMB.2012.12.009.
  7. [7]7. Kwon, D. Y.; Daily, J. W.; Kim, H. J.; Park, S. Antidiabetic Effects of Fermented Soybean Products on Type 2 Diabetes. Nutrition Research 2010, 30 (1), 1–13. https://doi.org/10.1016/J.NUTRES.2009.11.004.
  8. [8]8. Van Der Schouw, Y. T.; Pijpe, A.; Lebrun, C. E. I.; Bots, M. L.; Peeters, P. H. M.; Van Staveren, W. A.; Lamberts, S. W. J.; Grobbee, D. E. Higher Usual Dietary Intake of Phytoestrogens Is Associated with Lower Aortic Stiffness in Postmenopausal Women. Arterioscler Thromb Vasc Biol 2002, 22 (8), 1316–1322. https://doi.org/10.1161/01.atv.0000027176.83618.1a.
  9. [9]9. Talaei, M.; Pan, A. Role of Phytoestrogens in Prevention and Management of Type 2 Diabetes. World J Diabetes 2015, 6 (2), 271. https://doi.org/10.4239/WJD.V6.I2.271.
  10. [10]10. Ingram, D.; Sanders, K.; Kolybaba, M.; Lopez, D. Case-Control Study of Phyto-Oestrogens and Breast Cancer. Lancet 1997, 350 (9083), 990–994. https://doi.org/10.1016/s0140-6736(97)01339-1.
  11. [11]11. Rossouw, J. E.; Anderson, G. L.; Prentice, R. L.; LaCroix, A. Z.; Kooperberg, C.; Stefanick, M. L.; Jackson, R. D.; Beresford, S. A. A.; Howard, B. V.; Johnson, K. C.; Kotchen, J. M.; Ockene, J. Risk and Benefits of Estrogen plus Progestin in Healthy Postmenopausal Women. JAMA 2002, 288 (3), 321–333. https://doi.org/10.1001/jama.288.3.321.
  12. [12]12. Sites, C. K.; Toth, M. J.; Cushman, M.; L’Hommedieu, G. D.; Tchernof, A.; Tracy, R. P.; Poehlman, E. T. Menopause-Related Differences in Inflammation Markers and Their Relationship to Body Fat Distribution and Insulin-Stimulated Glucose Disposal. Fertil Steril 2002, 77 (1), 128–135. https://doi.org/10.1016/s0015-0282(01)02934-x.
  13. [13]13. Carr, M. C. The Emergence of the Metabolic Syndrome with Menopause. J Clin Endocrinol Metab 2003, 88 (6), 2404–2411. https://doi.org/10.1210/jc.2003-030242.
  14. [14]14. Pfeilschifter, J.; Köditz, R.; Pfohl, M.; Schatz, H. Changes in Proinflammatory Cytokine Activity after Menopause. Endocr Rev 2002, 23 (1), 90–119. https://doi.org/10.1210/edrv.23.1.0456.
  15. [15]15. DeFronzo, R. A.; Ferrannini, E. Insulin Resistance. A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease. Diabetes Care 1991, 14 (3), 173–194. https://doi.org/10.2337/diacare.14.3.173.
  16. [16]16. Prasannarong, M.; Saengsirisuwan, V.; Piyachaturawat, P.; Suksamrarn, A. Improvements of Insulin Resistance in Ovariectomized Rats by a Novel Phytoestrogen from Curcuma Comosa Roxb. BMC Complementary and Alternative Medicine 2012 12:1 2012, 12 (1), 1–11. https://doi.org/10.1186/1472-6882-12-28.
  17. [17]17. Zamora-Ros, R.; Knaze, V.; Luján-Barroso, L.; Kuhnle, G. G. C.; Mulligan, A. A.; Touillaud, M.; Slimani, N.; Romieu, I.; Powell, N.; Tumino, R.; Peeters, P. H. M.; De Magistris, M. S.; Ricceri, F.; Sonestedt, E.; Drake, I.; Hjartker, A.; Skie, G.; Mouw, T.; Wark, P. A.; Romaguera, D.; Bueno-De-Mesquita, H. B.; Ros, M.; Molina, E.; Sieri, S.; Quirós, J. R.; Huerta, J. M.; Tjønneland, A.; Halkjær, J.; Masala, G.; Teucher, B.; Kaas, R.; Travis, R. C.; Dilis, V.; Benetou, V.; Trichopoulou, A.; Amiano, P.; Ardanaz, E.; Boeing, H.; Förster, J.; Clavel-Chapelon, F.; Fagherazzi, G.; Perquier, F.; Johansson, G.; Johansson, I.; Cassidy, A.; Overvad, K.; González, C. A. Dietary Intakes and Food Sources of Phytoestrogens in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24-Hour Dietary Recall Cohort. Eur J Clin Nutr 2012, 66 (8), 932–941. https://doi.org/10.1038/EJCN.2012.36.
  18. [18]18. Viggiani, M. T.; Polimeno, L.; Di Leo, A.; Barone, M. Phytoestrogens: Dietary Intake, Bioavailability, and Protective Mechanisms against Colorectal Neoproliferative Lesions. Nutrients 2019, 11 (8). https://doi.org/10.3390/NU11081709.
  19. [19]19. Bennetau-Pelissero, C. Risks and Benefits of Phytoestrogens: Where Are We Now. Curr Opin Clin Nutr Metab Care 2016, 19 (6), 477–483. https://doi.org/10.1097/MCO.0000000000000326.
  20. [20]20. Domínguez-López, I.; Yago-Aragón, M.; Salas-Huetos, A.; Tresserra-Rimbau, A.; Hurtado-Barroso, S. Effects of Dietary Phytoestrogens on Hormones throughout a Human Lifespan: A Review. Nutrients 2020, Vol. 12, Page 2456 2020, 12 (8), 2456. https://doi.org/10.3390/NU12082456.
  21. [21]21. Wang, S.; Hu, Y.; Liu, B.; Li, Y.; Wang, M.; Sun, Q. Lignan Intake and Type 2 Diabetes Incidence Among US Men and Women. JAMA Netw Open 2024, 7 (8), e2426367. https://doi.org/10.1001/JAMANETWORKOPEN.2024.26367.
  22. [22]22. Farkas, S.; Szabó, A.; Hegyi, A. E.; Török, B.; Fazekas, C. L.; Ernszt, D.; Kovács, T.; Zelena, D. Estradiol and Estrogen-like Alternative Therapies in Use: The Importance of the Selective and Non-Classical Actions. Biomedicines 2022, 10 (4). https://doi.org/10.3390/BIOMEDICINES10040861.
  23. [23]23. Baudin, J.; Hernandez-Baixauli, J.; Quesada-Vázquez, S.; Mulero, F.; Puiggròs, F.; Arola, L.; Caimari, A. Combined Supplementation with Hesperidin, Phytosterols and Curcumin Decreases Adiposity and Improves Metabolic Health in Ovariectomized Rats. Food Funct 2024, 15 (9), 4905–4924. https://doi.org/10.1039/D3FO05122F.
  24. [24]24. Romani, A. M. P. The Controversy on the Beneficial Effect of Phytoestrogens in Diabetic Treatment in Postmenopausal Women. Biochem Pharmacol 2021, 190, 114619. https://doi.org/10.1016/J.BCP.2021.114619.
  25. [25]25. Glisic, M.; Kastrati, N.; Gonzalez-Jaramillo, V.; Bramer, W. M.; Ahmadizar, F.; Chowdhury, R.; Danser, A. H. J.; Roks, A. J. M.; Voortman, T.; Franco, O. H.; Muka, T. Associations between Phytoestrogens, Glucose Homeostasis, and Risk of Diabetes in Women: A Systematic Review and Meta-Analysis. Advances in Nutrition 2018, 9 (6), 726–740. https://doi.org/10.1093/ADVANCES/NMY048.
  26. [26]26. Cos, P.; De Bruyne, T.; Apers, S.; Vanden Berghe, D.; Pieters, L.; Vlietinck, A. J. Phytoestrogens: Recent Developments. Planta Med 2003, 69 (7), 589–599. https://doi.org/10.1055/S-2003-41122/ID/3/BIB.
  27. [27]27. Bateman, H. L.; Patisaul, H. B. Disrupted Female Reproductive Physiology Following Neonatal Exposure to Phytoestrogens or Estrogen Specific Ligands Is Associated with Decreased GnRH Activation and Kisspeptin Fiber Density in the Hypothalamus. Neurotoxicology 2008, 29 (6), 988–997. https://doi.org/10.1016/J.NEURO.2008.06.008.
  28. [28]28. Dixon, R. A. Phytoestrogens. Annu Rev Plant Biol 2004, 55 (Volume 55, 2004), 225–261. https://doi.org/10.1146/ANNUREV.ARPLANT.55.031903.141729/CITE/REFWORKS.
  29. [29]29. Delclos, K. B.; Bucci, T. J.; Lomax, L. G.; Latendresse, J. R.; Warbritton, A.; Weis, C. C.; Newbold, R. R. Effects of Dietary Genistein Exposure during Development on Male and Female CD (Sprague-Dawley) Rats. Reproductive Toxicology 2001, 15 (6), 647–663. https://doi.org/10.1016/S0890-6238(01)00177-0.
  30. [30]30. Iguchi, T.; Fukazawa, Y.; Uesugi, Y.; Takasugi, N. Polyovular Follicles in Mouse Ovaries Exposed Neonatally to Diethylstilbestrol in Vivo and in Vitro. Biol Reprod 1990, 43 (3), 478–484. https://doi.org/10.1095/BIOLREPROD43.3.478.
  31. [31]31. Losa, S. M.; Todd, K. L.; Sullivan, A. W.; Cao, J.; Mickens, J. A.; Patisaul, H. B. Neonatal Exposure to Genistein Adversely Impacts the Ontogeny of Hypothalamic Kisspeptin Signaling Pathways and Ovarian Development in the Peripubertal Female Rat. Reproductive Toxicology 2011, 31 (3), 280–289. https://doi.org/10.1016/J.REPROTOX.2010.10.002.
  32. [32]32. Ososki, A. L.; Kennelly, E. J. Phytoestrogens: A Review of the Present State of Research. Phytotherapy Research 2003, 17 (8), 845–869. https://doi.org/10.1002/PTR.1364.
  33. [33]33. Brandenberger, A. W.; Tee, M. K.; Lee, J. Y.; Chao, V.; Jaffe, R. B. Tissue Distribution of Estrogen Receptors Alpha (ER-α) and Beta (ER-β) MRNA in the Midgestational Human Fetus. J Clin Endocrinol Metab 1997, 82 (10), 3509–3512. https://doi.org/10.1210/JCEM.82.10.4400.
  34. [34]34. Cimafranca, M. A.; Davila, J.; Ekman, G. C.; Andrews, R. N.; Neese, S. L.; Peretz, J.; Woodling, K. A.; Helferich, W. G.; Sarkar, J.; Flaws, J. A.; Schantz, S. L.; Doerge, D. R.; Cooke, P. S. Acute and Chronic Effects of Oral Genistein Administration in Neonatal Mice. Biol Reprod 2010, 83 (1), 114–121. https://doi.org/10.1095/BIOLREPROD.109.080549.
  35. [35]35. Jefferson, W. N.; Couse, J. F.; Padilla-Banks, E.; Korach, K. S.; Newbold, R. R. Neonatal Exposure to Genistein Induces Estrogen Receptor (ER)α Expression and Multioocyte Follicles in the Maturing Mouse Ovary: Evidence for ERβ-Mediated and Nonestrogenic Actions. Biol Reprod 2002, 67 (4), 1285–1296. https://doi.org/10.1095/BIOLREPROD67.4.1285.

Authors (5)

Jai Shankar Pandey

Faculty of Nursing and Paramed...

View all publications →

Prashant Kumar

Guru Shree Gorakshnath Chikits...

View all publications →

Aditya Kumar Jaiswal

Faculty of Nursing and Paramed...

View all publications →

Rohit Rajak

Faculty of Nursing and Paramed...

View all publications →

Shubham Kumar Maurya

Faculty of Nursing and Paramed...

View all publications →

Download Article

PDF

Best for printing and citation

File size: 2.1 MB
Format: PDF

Download Article

PDF

Best for printing and citation

File size: 2.1 MB
Format: PDF

Article Information

Published in:

IJPHDT, Vol-3, Issue-04, April-2026 (Vol. 3, Issue 4, 2026)

IJPHDT430013

IJPHDT-01-000243

127-173

2026-04-28

Article Impact

Views:1,552
Downloads:1,846
scite_
PlumX Metrics Badge

How to Cite

Shankar, J., & Kumar & Kumar, A. & Rajak & Kumar, S. (2026). Phytoestrogens for Polycystic Ovary Syndrome (PCOS): Natural Approaches to Hormonal Balance. International Journal of Pharmacognosy and Herbal Drug Technology, 3(4), 127-173. DOI:https://doi.org/10.64063/3049-1630.vol3.issue4.000243

Article Actions

Whatsapp